# Francesco Scolari

**Type:** Researchers  
**Canonical URL:** https://scholariq.org/researchers/francesco-scolari/

## Facts

| Field | Value |
| --- | --- |
| Citations | 22,950 |
| Field | Renal Diseases and Glomerulopathies |
| h-index | 68 |
| i10-index | 163 |
| Last Known Institution | Surgical Specialties (Canada) |
| OpenAlex ID | https://openalex.org/A5047786318 |
| ORCID iD | https://orcid.org/0000-0003-0233-9705 |
| Works | 347 |

## Researcher papers

- [Renoprotective properties of ACE-inhibition in non-diabetic nephropathies with non-nephrotic proteinuria](https://scholariq.org/papers/renoprotective-properties-of-ace-inhibition-in-non-diabetic-nephropathies-with/)
- [The Pathophysiology of IgA Nephropathy](https://scholariq.org/papers/the-pathophysiology-of-iga-nephropathy/)
- [Discovery of new risk loci for IgA nephropathy implicates genes involved in immunity against intestinal pathogens](https://scholariq.org/papers/discovery-of-new-risk-loci-for-iga-nephropathy-implicates-genes-involved-in/)
- [Genome-wide association study identifies susceptibility loci for IgA nephropathy](https://scholariq.org/papers/genome-wide-association-study-identifies-susceptibility-loci-for-iga-nephropathy/)
- [Geographic Differences in Genetic Susceptibility to IgA Nephropathy: GWAS Replication Study and Geospatial Risk Analysis](https://scholariq.org/papers/geographic-differences-in-genetic-susceptibility-to-iga-nephropathy-gwas/)
- [A randomized study comparing methylprednisolone plus chlorambucil versus methylprednisolone plus cyclophosphamide in idiopathic membranous nephropathy.](https://scholariq.org/papers/a-randomized-study-comparing-methylprednisolone-plus-chlorambucil-versus/)
- [IgA nephropathy, the most common cause of glomerulonephritis, is linked to 6q22–23](https://scholariq.org/papers/iga-nephropathy-the-most-common-cause-of-glomerulonephritis-is-linked-to-6q22-23/)
- [Rituximab or Cyclophosphamide in the Treatment of Membranous Nephropathy: The RI-CYCLO Randomized Trial](https://scholariq.org/papers/rituximab-or-cyclophosphamide-in-the-treatment-of-membranous-nephropathy-the-ri/)
- [The copy number variation landscape of congenital anomalies of the kidney and urinary tract](https://scholariq.org/papers/the-copy-number-variation-landscape-of-congenital-anomalies-of-the-kidney-and/)
- [Genetics in chronic kidney disease: conclusions from a Kidney Disease: Improving Global Outcomes (KDIGO) Controversies Conference](https://scholariq.org/papers/genetics-in-chronic-kidney-disease-conclusions-from-a-kidney-disease-improving/)
- [Genetic Drivers of Kidney Defects in the DiGeorge Syndrome](https://scholariq.org/papers/genetic-drivers-of-kidney-defects-in-the-digeorge-syndrome/)

## Researcher topics

- [Renal Diseases and Glomerulopathies](https://scholariq.org/topics/renal-diseases-and-glomerulopathies/)
- [Genetic and Kidney Cyst Diseases](https://scholariq.org/topics/genetic-and-kidney-cyst-diseases/)
- [Renal and related cancers](https://scholariq.org/topics/renal-and-related-cancers/)
- [Vasculitis and related conditions](https://scholariq.org/topics/vasculitis-and-related-conditions-2/)
- [Chronic Kidney Disease and Diabetes](https://scholariq.org/topics/chronic-kidney-disease-and-diabetes/)

## Researcher university

- [Surgical Specialties (Canada)](https://scholariq.org/institutions/surgical-specialties-canada/)

---
Source: ScholarIQ — public research metadata, principally OpenAlex. See https://scholariq.org/sources/ for provenance and https://scholariq.org/methodology/ for what these figures mean.